|
US5728536A
(en)
|
1993-07-29 |
1998-03-17 |
St. Jude Children's Research Hospital |
Jak kinases and regulation of Cytokine signal transduction
|
|
US6004981A
(en)
|
1996-03-08 |
1999-12-21 |
Berlex Laboratories, Inc. |
Benzamidine derivatives and their use as anti-coagulants
|
|
US5691364A
(en)
*
|
1995-03-10 |
1997-11-25 |
Berlex Laboratories, Inc. |
Benzamidine derivatives and their use as anti-coagulants
|
|
ES2208737T3
(es)
|
1995-03-10 |
2004-06-16 |
Berlex Laboratories, Inc. |
Derivados de benzamidina, su preparacion y su utilizacion como anticoagulantes.
|
|
US6316635B1
(en)
|
1995-06-07 |
2001-11-13 |
Sugen, Inc. |
2-indolinone derivatives as modulators of protein kinase activity
|
|
US5811428A
(en)
|
1995-12-18 |
1998-09-22 |
Signal Pharmaceuticals, Inc. |
Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions
|
|
EP0850228A1
(en)
|
1995-09-01 |
1998-07-01 |
Signal Pharmaceuticals, Inc. |
Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions
|
|
US6696448B2
(en)
|
1996-06-05 |
2004-02-24 |
Sugen, Inc. |
3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors
|
|
CN1234798A
(zh)
|
1996-09-12 |
1999-11-10 |
舍林股份公司 |
环状氨基酸和环状羟基羧酸衍生物取代的苄脒衍生物和它们用作抗凝剂的用途
|
|
US6008234A
(en)
|
1996-09-12 |
1999-12-28 |
Berlex Laboratories, Inc. |
Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants
|
|
US6004985A
(en)
|
1996-10-09 |
1999-12-21 |
Berlex Laboratories, Inc. |
Thio acid derived monocylic N-heterocyclics as anticoagulants
|
|
US6486185B1
(en)
|
1997-05-07 |
2002-11-26 |
Sugen, Inc. |
3-heteroarylidene-2-indolinone protein kinase inhibitors
|
|
US6316429B1
(en)
|
1997-05-07 |
2001-11-13 |
Sugen, Inc. |
Bicyclic protein kinase inhibitors
|
|
GB9718913D0
(en)
|
1997-09-05 |
1997-11-12 |
Glaxo Group Ltd |
Substituted oxindole derivatives
|
|
US6133305A
(en)
|
1997-09-26 |
2000-10-17 |
Sugen, Inc. |
3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activity
|
|
US6686364B2
(en)
|
1997-12-08 |
2004-02-03 |
Berlex Laboratories, Inc. |
Benzamidine derivatives and their use as anti-coagulants
|
|
WO1999031073A1
(en)
|
1997-12-15 |
1999-06-24 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel pyrimidine-5-carboxamide derivatives
|
|
WO2000000202A1
(en)
|
1998-06-30 |
2000-01-06 |
Parker Hughes Institute |
Method for inhibiting c-jun expression using jak-3 inhibitors
|
|
HUP0103386A3
(en)
|
1998-08-21 |
2002-07-29 |
Parker Hughes Inst St Paul |
Use of quinazoline derivatives for producing pharmaceutical compositions having jak 3-inhibitor effect
|
|
US6262088B1
(en)
|
1998-11-19 |
2001-07-17 |
Berlex Laboratories, Inc. |
Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
|
|
US6127376A
(en)
|
1998-12-04 |
2000-10-03 |
Berlex Laboratories, Inc. |
Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants
|
|
GB9828511D0
(en)
|
1998-12-24 |
1999-02-17 |
Zeneca Ltd |
Chemical compounds
|
|
US6841567B1
(en)
|
1999-02-12 |
2005-01-11 |
Cephalon, Inc. |
Cyclic substituted fused pyrrolocarbazoles and isoindolones
|
|
US6624171B1
(en)
|
1999-03-04 |
2003-09-23 |
Smithkline Beecham Corporation |
Substituted aza-oxindole derivatives
|
|
GB9904995D0
(en)
|
1999-03-04 |
1999-04-28 |
Glaxo Group Ltd |
Substituted aza-oxindole derivatives
|
|
US6080747A
(en)
|
1999-03-05 |
2000-06-27 |
Hughes Institute |
JAK-3 inhibitors for treating allergic disorders
|
|
GB9905075D0
(en)
|
1999-03-06 |
1999-04-28 |
Zeneca Ltd |
Chemical compounds
|
|
US7125875B2
(en)
|
1999-04-15 |
2006-10-24 |
Bristol-Myers Squibb Company |
Cyclic protein tyrosine kinase inhibitors
|
|
US6797706B1
(en)
*
|
1999-06-09 |
2004-09-28 |
Yamanouchi Pharmaceutical Co., Ltd. |
Heterocyclecarboxamide derivative
|
|
AU5108000A
(en)
*
|
1999-06-10 |
2001-01-02 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel nitrogen-contaiing heterocyclic derivatives or salts thereof
|
|
GB9918035D0
(en)
|
1999-07-30 |
1999-09-29 |
Novartis Ag |
Organic compounds
|
|
AU4903201A
(en)
|
1999-11-30 |
2001-07-03 |
Parker Hughes Institute |
Inhibitors of thrombin induced platelet aggregation
|
|
SK287188B6
(sk)
|
1999-12-10 |
2010-02-08 |
Pfizer Products Inc. |
Pyrolo [2,3-d]pyrimidínová zlúčenina, jej použitie a farmaceutická kompozícia alebo kombinácia s jej obsahom
|
|
ES2245955T3
(es)
|
1999-12-21 |
2006-02-01 |
Sugen, Inc. |
7-aza-indolin-2-onas 4-sustituidas y su utilizacion como inhibidores de proteina-quinasa.
|
|
US20020065270A1
(en)
|
1999-12-28 |
2002-05-30 |
Moriarty Kevin Joseph |
N-heterocyclic inhibitors of TNF-alpha expression
|
|
WO2001052892A2
(en)
|
2000-01-24 |
2001-07-26 |
Genzyme Corporation |
Jak/stat pathway inhibitors and the uses thereof
|
|
HUP0204271A3
(en)
|
2000-01-31 |
2003-07-28 |
Pfizer Prod Inc |
Pyrimidine carboxamides useful as inhibitors of pde4 isozymes, pharmaceutical compositions containing them and their use
|
|
IL145757A
(en)
|
2000-02-05 |
2007-12-03 |
Vertex Pharma |
History of pyrazole and pharmaceutical preparations containing them
|
|
CA2369076A1
(en)
|
2000-02-05 |
2001-08-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compositions useful as inhibitors of erk
|
|
GB0004888D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
US6525051B2
(en)
|
2000-03-27 |
2003-02-25 |
Schering Aktiengesellschaft |
N-heterocyclic derivatives as NOS inhibitors
|
|
US6608048B2
(en)
|
2000-03-28 |
2003-08-19 |
Wyeth Holdings |
Tricyclic protein kinase inhibitors
|
|
AR028261A1
(es)
|
2000-03-28 |
2003-04-30 |
Wyeth Corp |
Inhibidores triciclicos de la proteina quinasa
|
|
CA2406562C
(en)
|
2000-05-08 |
2009-09-15 |
Janssen Pharmaceutica N.V. |
Hiv replication inhibiting pyrimidines and triazines
|
|
CN100351253C
(zh)
|
2000-06-26 |
2007-11-28 |
辉瑞产品公司 |
作为免疫抑制剂的吡咯并[2,3－d]嘧啶化合物
|
|
GB0016877D0
(en)
|
2000-07-11 |
2000-08-30 |
Astrazeneca Ab |
Chemical compounds
|
|
WO2002043735A1
(en)
|
2000-11-29 |
2002-06-06 |
Parker Hughes Institute |
Inhibitors of thrombin induced platelet aggregation
|
|
US20020115173A1
(en)
|
2000-12-11 |
2002-08-22 |
Children's Medical Center Corporation |
Short peptides from the 'A-region' of protein kinases which selectively modulate protein kinase activity
|
|
AR035721A1
(es)
|
2000-12-20 |
2004-07-07 |
Sugen Inc |
Indolinonas 4-aril sustituidas; sus composiciones farmaceuticas y metodo para modular la actividad catalitica de una proteina quinasa
|
|
JP4253188B2
(ja)
|
2000-12-21 |
2009-04-08 |
グラクソ グループ リミテッド |
血管新生制御剤としてのピリミジンアミン
|
|
FR2818642B1
(fr)
|
2000-12-26 |
2005-07-15 |
Hoechst Marion Roussel Inc |
Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilistion
|
|
AUPR279101A0
(en)
|
2001-01-30 |
2001-02-22 |
Cytopia Pty Ltd |
Protein kinase signalling
|
|
US20040102455A1
(en)
|
2001-01-30 |
2004-05-27 |
Burns Christopher John |
Method of inhibiting kinases
|
|
SE0101675D0
(sv)
|
2001-05-11 |
2001-05-11 |
Astrazeneca Ab |
Novel composition
|
|
WO2002096888A1
(de)
|
2001-05-29 |
2002-12-05 |
Schering Aktiengesellschaft |
Cdk inhibitorische pyrimidine, deren herstellung und verwendung als arzneimittel
|
|
US7301023B2
(en)
|
2001-05-31 |
2007-11-27 |
Pfizer Inc. |
Chiral salt resolution
|
|
ATE432929T1
(de)
|
2001-06-15 |
2009-06-15 |
Vertex Pharma |
5-(2-aminopyrimidin-4-yl)benzisoxazole als proteinkinasehemmer
|
|
US6433018B1
(en)
|
2001-08-31 |
2002-08-13 |
The Research Foundation Of State University Of New York |
Method for reducing hypertrophy and ischemia
|
|
WO2003020698A2
(en)
|
2001-09-06 |
2003-03-13 |
Prochon Biotech Ltd. |
Protein tyrosine kinase inhibitors
|
|
CA2459879A1
(en)
|
2001-09-10 |
2003-03-20 |
Sugen, Inc. |
3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene)-2-indolinone derivatives as kinase inhibitors
|
|
WO2003030909A1
(en)
|
2001-09-25 |
2003-04-17 |
Bayer Pharmaceuticals Corporation |
2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
|
|
US6642232B2
(en)
|
2001-10-10 |
2003-11-04 |
Sugen, Inc. |
3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitors
|
|
GT200200234A
(es)
|
2001-12-06 |
2003-06-27 |
|
Compuestos cristalinos novedosos
|
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
US6998391B2
(en)
|
2002-02-07 |
2006-02-14 |
Supergen.Inc. |
Method for treating diseases associated with abnormal kinase activity
|
|
AU2003209077A1
(en)
|
2002-02-08 |
2003-09-02 |
Smithkline Beecham Corporation |
Pyrimidine compounds
|
|
EP1487824B1
(en)
|
2002-03-01 |
2007-06-20 |
SmithKline Beecham Corporation |
Diamino-pyrimidines and their use as angiogenesis inhibitors
|
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
|
ATE489384T1
(de)
|
2002-05-06 |
2010-12-15 |
Vertex Pharma |
Thiadiazole oder oxadiazole und ihre verwendung als jak proteinkinaseinhibitoren
|
|
AU2003231231A1
(en)
|
2002-05-06 |
2003-11-11 |
Bayer Pharmaceuticals Corporation |
Pyridinyl amino pyrimidine derivatives useful for treating hyper-proliferative disorders
|
|
JP2005528443A
(ja)
|
2002-05-30 |
2005-09-22 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ｊａｋキナーゼおよびｃｄｋ２プロテインキナーゼのインヒビター
|
|
JP2005529954A
(ja)
|
2002-06-17 |
2005-10-06 |
スミスクライン ビーチャム コーポレーション |
化学プロセス
|
|
US7449456B2
(en)
|
2002-06-28 |
2008-11-11 |
Astellas Pharma, Inc. |
Diaminopyrimidinecarboxamide derivative
|
|
BR0313059B8
(pt)
|
2002-07-29 |
2021-07-27 |
Rigel Pharmaceuticals |
composto, e, composição farmacêutica
|
|
PL375447A1
(en)
|
2002-08-14 |
2005-11-28 |
Vertex Pharmaceuticals Incorporated |
Protein kinase inhibitors and uses thereof
|
|
EP2172460A1
(en)
|
2002-11-01 |
2010-04-07 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of JAK and other protein kinases
|
|
WO2004041814A1
(en)
|
2002-11-04 |
2004-05-21 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl-pyramidine derivatives as jak inhibitors
|
|
CA2507406A1
(en)
|
2002-11-05 |
2004-05-21 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of jak and other protein kinases
|
|
CL2003002353A1
(es)
|
2002-11-15 |
2005-02-04 |
Vertex Pharma |
Compuestos derivados de diaminotriazoles, inhibidores d ela proteina quinasa; composicion farmaceutica; procedimiento de preparacion; y su uso del compuesto en el tratamiento de enfermedades de desordenes alergicos, proliferacion, autoinmunes, condic
|
|
CN1726192A
(zh)
|
2002-11-21 |
2006-01-25 |
辉瑞产品公司 |
3－氨基－哌啶衍生物及其制备方法
|
|
JP2006509000A
(ja)
|
2002-11-26 |
2006-03-16 |
ファイザー・プロダクツ・インク |
移植片拒絶反応の処置の方法
|
|
AU2003297160A1
(en)
|
2002-12-18 |
2004-07-22 |
Vertex Pharmaceuticals Incorporated |
Benzisoxazole derivatives useful as inhibitors of protein kinases
|
|
EP1597251B1
(en)
|
2003-02-20 |
2009-06-10 |
SmithKline Beecham Corporation |
Pyrimidine compounds
|
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
|
CA2522595A1
(en)
|
2003-04-03 |
2004-10-28 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of protein kinases
|
|
US7504396B2
(en)
|
2003-06-24 |
2009-03-17 |
Amgen Inc. |
Substituted heterocyclic compounds and methods of use
|
|
AU2004259734A1
(en)
|
2003-07-24 |
2005-02-03 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
PT1656372E
(pt)
|
2003-07-30 |
2013-06-27 |
Rigel Pharmaceuticals Inc |
Métodos para o tratamento ou prevenção de doenças autoimunes com compostos de 2,4-pirimidinadiamina
|
|
BRPI0413469A
(pt)
|
2003-08-14 |
2006-10-17 |
Pfizer |
derivados de piperazina para o tratamento de infecções por hiv
|
|
SI2287156T1
(sl)
|
2003-08-15 |
2013-09-30 |
Novartis Ag |
2,4-di(fenilamino)-pirimidini, uporabni pri zdravljenju neoplastičnih bolezni, vnetnih motenj in motenj imunskega sistema
|
|
AR045595A1
(es)
|
2003-09-04 |
2005-11-02 |
Vertex Pharma |
Composiciones utiles como inhibidores de proteinas quinasas
|
|
GB0321710D0
(en)
|
2003-09-16 |
2003-10-15 |
Novartis Ag |
Organic compounds
|
|
WO2005033086A1
(en)
|
2003-09-30 |
2005-04-14 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
|
US7309790B2
(en)
|
2003-10-03 |
2007-12-18 |
Pfizer Inc |
Chemical compounds
|
|
DE10349423A1
(de)
|
2003-10-16 |
2005-06-16 |
Schering Ag |
Sulfoximinsubstituierte Parimidine als CDK- und/oder VEGF-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel
|
|
EP1704145B1
(en)
|
2004-01-12 |
2012-06-13 |
YM BioSciences Australia Pty Ltd |
Selective kinase inhibitors
|
|
PL2332940T3
(pl)
|
2004-03-30 |
2013-03-29 |
Vertex Pharma |
Azaindole użyteczne jako inhibitory JAK i innych kinaz białkowych
|
|
GB0407723D0
(en)
|
2004-04-05 |
2004-05-12 |
Novartis Ag |
Organic compounds
|
|
JP4876915B2
(ja)
|
2004-06-14 |
2012-02-15 |
日本電気株式会社 |
フィルム外装電気デバイス
|
|
WO2006027377A1
(en)
|
2004-09-10 |
2006-03-16 |
Altana Pharma Ag |
Ciclesonide and syk inhibitor combination and methods of use thereof
|
|
EP1791538A1
(en)
|
2004-09-10 |
2007-06-06 |
Altana Pharma AG |
Roflumilast and syk inhibitor combination and methods of use thereof
|
|
SI1814878T1
(sl)
|
2004-11-24 |
2012-06-29 |
Rigel Pharmaceuticals Inc |
Spojine spiro-2,4-pirimidindiamina in njihova uporaba
|
|
CA2591948C
(en)
|
2005-01-19 |
2013-11-12 |
Rigel Pharmaceuticals, Inc. |
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
|
|
WO2007027238A2
(en)
|
2005-05-03 |
2007-03-08 |
Rigel Pharmaceuticals, Inc. |
Jak kinase inhibitors and their uses
|
|
EP1948658A1
(en)
|
2005-10-13 |
2008-07-30 |
Glaxo Group Limited |
Pyrrolopyrimidine derivatives as syk inhibitors
|
|
WO2007046112A1
(en)
|
2005-10-19 |
2007-04-26 |
Suven Life Sciences Inc. |
Arylthioether tryptamine derivatives as functional 5-ht6 ligands
|
|
EP1960372B1
(en)
|
2005-12-15 |
2015-12-09 |
Rigel Pharmaceuticals, Inc. |
Kinase inhibitors and their uses
|
|
NL2000323C2
(nl)
|
2005-12-20 |
2007-11-20 |
Pfizer Ltd |
Pyrimidine-derivaten.
|
|
GB0526246D0
(en)
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
|
EP2004632B1
(en)
|
2006-03-30 |
2014-03-12 |
Janssen R&D Ireland |
Hiv inhibiting 5-amido substituted pyrimidines
|
|
EP2041132A2
(en)
|
2006-07-06 |
2009-04-01 |
Boehringer Ingelheim International GmbH |
New compounds
|
|
JP2009544592A
(ja)
|
2006-07-21 |
2009-12-17 |
ノバルティス アクチエンゲゼルシャフト |
Ｊａｋキナーゼ阻害剤としての２，４−ジ（アリールアミノ）−ピリミジン−５−カルボキサミド化合物
|
|
WO2008024963A1
(en)
|
2006-08-24 |
2008-02-28 |
Serenex, Inc. |
Benzene, pyridine, and pyridazine derivatives
|
|
NZ576425A
(en)
|
2006-10-23 |
2012-04-27 |
Cephalon Inc |
Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and c-met inhibitors
|
|
US20080139531A1
(en)
|
2006-12-04 |
2008-06-12 |
Alcon Manufacturing Ltd. |
Use of connective tissue mast cell stabilizers to facilitate ocular surface re-epithelization and wound repair
|
|
MX2009007006A
(es)
|
2006-12-29 |
2009-07-09 |
Tibotec Pharm Ltd |
Pirimidinas 5,6-sustituidas inhibidoras del virus de inmunodeficiencia humana.
|
|
US20110160185A9
(en)
|
2007-04-02 |
2011-06-30 |
Jorge Salas Solana |
Pyrrolopyrimidine derivatives as jak3 inhibitors
|
|
EP2152702B1
(en)
|
2007-05-04 |
2011-08-24 |
AstraZeneca AB |
Amino-thiazolyl- pyrimidine derivatives and their use for the treatment of cancer
|
|
EP2157090A4
(en)
|
2007-06-21 |
2011-09-07 |
Taisho Pharmaceutical Co Ltd |
PYRAZINAMIDE COMPOUND
|
|
BRPI0815979A2
(pt)
|
2007-08-28 |
2017-06-13 |
Irm Llc |
compostos e composições com inibidores de quinase, bem como uso dos mesmos
|
|
US20100292447A1
(en)
|
2007-10-12 |
2010-11-18 |
Merck Patent Gesellschaft |
Method and agent for refolding proteins
|
|
US20090270418A1
(en)
*
|
2008-01-09 |
2009-10-29 |
Marianne Sloss |
Pyrazole pyrazine amine compounds as kinase inhibitors, compositions thereof and methods of treatment therewith
|
|
US20090196973A1
(en)
|
2008-02-01 |
2009-08-06 |
Rich Products Corporation |
Foam Compositions
|
|
CA2960692C
(en)
|
2008-04-16 |
2019-09-24 |
Portola Pharmaceuticals, Inc. |
2,6-diamino-pyrimidin-5-yl-carboxamides as syk or jak kinase inhibitors
|
|
SG2014015085A
(en)
*
|
2008-04-16 |
2014-06-27 |
Portola Pharm Inc |
2,6-diamino-pyrimidin-5-yl-carboxamides as syk or jak kinases inhibitors
|
|
US8138339B2
(en)
|
2008-04-16 |
2012-03-20 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
|
AU2009244897B2
(en)
|
2008-04-16 |
2014-11-13 |
Alexion Pharmaceuticals, Inc. |
2, 6-diamino- pyrimidin- 5-yl-carboxamides as syk or JAK kinases inhibitors
|
|
EP2271631B1
(en)
|
2008-04-22 |
2018-07-04 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
|
KR20110060894A
(ko)
*
|
2008-09-18 |
2011-06-08 |
아스테라스 세이야쿠 가부시키가이샤 |
복소환 카르복사미드 화합물
|
|
EP2361902A4
(en)
|
2008-11-21 |
2012-04-25 |
Astellas Pharma Inc |
4,6-DIAMINONICOTINSÄUREAMIDVERBINDUNG
|
|
US8575153B2
(en)
|
2008-11-28 |
2013-11-05 |
Kowa Company, Ltd. |
Pyridine-3-carboxyamide derivative
|
|
ES2433109T3
(es)
|
2009-01-13 |
2013-12-09 |
Glaxo Group Limited |
Derivados de pirimidin-carboxamida como inhibidores de la Syk cinasa
|
|
AR076550A1
(es)
|
2009-05-06 |
2011-06-22 |
Portola Pharm Inc |
Inhibidores de la janus tirosina kinasa (jak)
|
|
WO2010128659A1
(ja)
*
|
2009-05-08 |
2010-11-11 |
アステラス製薬株式会社 |
ジアミノへテロ環カルボキサミド化合物
|
|
EP2621489A1
(en)
|
2010-09-30 |
2013-08-07 |
Portola Pharmaceuticals, Inc. |
Combinations of 4-(cyclopropylamino)-2-(4-(4-(ethylsulfonyl)piperazin-1-yl)phenylamino)pyrimidine-5-carboxamide and fludarabine
|
|
US20130244963A1
(en)
|
2010-09-30 |
2013-09-19 |
Portola Pharmaceuticals, Inc. |
Combination therapy with 4-(3-(2h-1,2,3-triazol-2-yl)phenylamino)-2-((1r,2s)-2-aminocyclohexylamino)pyrimidine-5-carboxamide
|
|
JP2014005206A
(ja)
|
2010-10-22 |
2014-01-16 |
Astellas Pharma Inc |
アリールアミノヘテロ環カルボキサミド化合物
|
|
US9102625B2
(en)
|
2010-11-01 |
2015-08-11 |
Portola Pharmaceuticals, Inc. |
Nicotinamides as JAK kinase modulators
|
|
WO2012061415A1
(en)
|
2010-11-01 |
2012-05-10 |
Portola Pharmaceuticals, Inc. |
Oxypyrimidines as syk modulators
|
|
EP2782580A4
(en)
|
2011-11-23 |
2015-10-07 |
Portola Pharm Inc |
SELECTIVE INHIBITORS OF KINASES
|
|
BR112014012396B1
(pt)
|
2011-11-23 |
2020-08-25 |
Portola Pharmaceuticals, Inc |
inibidores de pirazina quinase, composição, método in vitro para inibição de quinase syk ou via de transdução de sinal, uso dos referidos inibidores e kit
|